-
1
-
-
84888115148
-
Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: Systematic review and meta-analysis
-
P. Kawalec, A. Mikrut, N. Wis̈niewska, and A. Pilc Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis Arch Med Sci 9 2013 765 779
-
(2013)
Arch Med Sci
, vol.9
, pp. 765-779
-
-
Kawalec, P.1
Mikrut, A.2
Wis̈niewska, N.3
Pilc, A.4
-
2
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
P. Rutgeerts, W.J. Sandborn, B.G. Feagan, and et al. Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
3
-
-
84886535730
-
Efficacy and adverse reactions of the TNF alpha inhibitor infliximab in rheumatoid arthritis
-
T. Imagama, and T. Taguchi Efficacy and adverse reactions of the TNF alpha inhibitor infliximab in rheumatoid arthritis Nihon Rinsho 71 2013 1209 1213
-
(2013)
Nihon Rinsho
, vol.71
, pp. 1209-1213
-
-
Imagama, T.1
Taguchi, T.2
-
4
-
-
84873438927
-
Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: Review of current data
-
M.H. Rustin Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data Br J Dermatol 167 suppl 3 2012 3 11
-
(2012)
Br J Dermatol
, vol.167
, pp. 3-11
-
-
Rustin, M.H.1
-
5
-
-
0038649858
-
The incidence and management of infusion reactions to infliximab: A large center experience
-
A. Cheifetz, M. Smedley, S. Martin, and et al. The incidence and management of infusion reactions to infliximab: a large center experience Am J Gastroenterol 98 2003 1315 1324
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1315-1324
-
-
Cheifetz, A.1
Smedley, M.2
Martin, S.3
-
6
-
-
84865704139
-
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction
-
A. Vultaggio, A. Matucci, F. Nencini, S. Pratesi, and E. Maggi Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction Intern Emerg Med 7 suppl 2 2012 S77 S79
-
(2012)
Intern Emerg Med
, vol.7
, pp. S77-S79
-
-
Vultaggio, A.1
Matucci, A.2
Nencini, F.3
Pratesi, S.4
Maggi, E.5
-
7
-
-
84878358699
-
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab
-
A. Matucci, S. Pratesi, G. Petroni, and et al. Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab Clin Exp Allergy 43 2013 659 664
-
(2013)
Clin Exp Allergy
, vol.43
, pp. 659-664
-
-
Matucci, A.1
Pratesi, S.2
Petroni, G.3
-
9
-
-
0035007087
-
Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction
-
T.C. Puchner, S. Kugathasan, K.J. Kelly, and D.G. Binion Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction Inflamm Bowel Dis 7 2001 34 37
-
(2001)
Inflamm Bowel Dis
, vol.7
, pp. 34-37
-
-
Puchner, T.C.1
Kugathasan, S.2
Kelly, K.J.3
Binion, D.G.4
-
10
-
-
33747356696
-
Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions
-
C. Duburque, J. Lelong, R. Iacob, and et al. Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions Aliment Pharmacol Ther 24 2006 851 858
-
(2006)
Aliment Pharmacol Ther
, vol.24
, pp. 851-858
-
-
Duburque, C.1
Lelong, J.2
Iacob, R.3
-
11
-
-
71349084892
-
Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
-
P.J. Brennan, T. Rodriguez Bouza, F.I. Hsu, D.E. Sloane, and M.C. Castells Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment J Allergy Clin Immunol 124 2009 1259 1266
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 1259-1266
-
-
Brennan, P.J.1
Rodriguez Bouza, T.2
Hsu, F.I.3
Sloane, D.E.4
Castells, M.C.5
-
12
-
-
84876359766
-
Elective switching from infliximab to adalimumab in stable Crohn's disease
-
F. Hoentjen, B.J. Haarhuis, J.P. Drenth, and D.J. de Jong Elective switching from infliximab to adalimumab in stable Crohn's disease Inflamm Bowel Dis 19 2013 761 766
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 761-766
-
-
Hoentjen, F.1
Haarhuis, B.J.2
Drenth, J.P.3
De Jong, D.J.4
-
14
-
-
0037434552
-
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
-
F. Baert, M. Noman, S. Vermeire, and et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease N Engl J Med 348 2003 601 608
-
(2003)
N Engl J Med
, vol.348
, pp. 601-608
-
-
Baert, F.1
Noman, M.2
Vermeire, S.3
-
15
-
-
0031457407
-
Allergic reactions to drugs and biologic agents
-
R.D. deShazo, and S.F. Kemp Allergic reactions to drugs and biologic agents JAMA 278 1997 1895 1906
-
(1997)
JAMA
, vol.278
, pp. 1895-1906
-
-
deShazo, R.D.1
Kemp, S.F.2
|